Effect of Finasteride Treatment and Its Withdrawal in the Rat Corpus Cavernosum

    Prof Silvia Giatti, Silvia Diviccaro, Lucia Cioffi, P Mitro, Paola Caruso, Prof Roberto C Melcangi
    Image of study
    TLDR Finasteride treatment may cause erectile dysfunction, but stopping it reverses these effects.
    The study investigated the effects of finasteride treatment and its withdrawal on erectile function in male rats. Finasteride treatment led to molecular changes indicative of erectile dysfunction, including increased plasma norepinephrine, decreased epinephrine, reduced 5α-reductase type II protein levels in the corpus cavernosum, and decreased activity of nitric oxide synthase and ornithine transcarbamylase. These changes were not observed after withdrawal of the drug. The findings suggest that finasteride treatment, but not its withdrawal, induces molecular alterations that may contribute to erectile dysfunction. Future research will explore the impact of finasteride withdrawal on neural circuits controlling male sexual behavior.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Why does it seem everyone favors finasteride over dutasteride?

      in Female  62 upvotes 1 year ago
      The conversation discusses preferences for hair loss treatments, specifically finasteride over dutasteride. Users share personal experiences, cost considerations, FDA approval status, and potential side effects, with some switching between treatments to find what works best for them.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 8 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

    Related Research

    1 / 1 results